SCHEMBL986919

SCHEMBL986919

COc1cc(C(=O)O)cc(OC)c1OC(C)C

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TPMT P51580 2/20 0.61
CA12 O43570 2/20 0.58
CA1 P00915 2/20 0.58
CA2 P00918 2/20 0.58
CA4 P22748 2/20 0.58
CA6 P23280 2/20 0.58
CA7 P43166 2/20 0.58
CA9 Q16790 2/20 0.58
CA14 Q9ULX7 2/20 0.58
CA3 P07451 1/20 0.58
PKM P14618 1/20 0.58
CA5A P35218 1/20 0.58
CA5B Q9Y2D0 1/20 0.58
PTGS2 P35354 1/20 0.55
HTT P42858 2/20 0.49
CNR2 P34972 1/20 0.49
KMT2A Q03164 3/20 0.48
MAPK1 P28482 2/20 0.47
TUBB4A P04350 3/20 0.45
TUBB P07437 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11893913 0.90 TPMT (0.54) TPMTCA12CA1CA2CA4
SCHEMBL1458531 0.89 KMT2A (0.50) TPMTCA12CA1CA2CA4
SCHEMBL12492185 0.89 TPMT (0.53) TPMTCA12CA1CA2CA4
SCHEMBL1458091 0.85 TPMT (0.56) TPMTCA12CA1CA2CA4
SCHEMBL4039970 0.84 MAPT (0.47) TPMTCA12CA1CA2CA7
SCHEMBL8350902 0.84 TPMT (0.59) TPMTCA12CA1CA2CA4
SCHEMBL28134645 0.83 TPMT (0.54) TPMTCA12CA1CA2CA4
3,4,5-Trimethoxybenzoic Acid SCHEMBL6592 0.82 TPMT (0.78) TPMTCA12CA1CA2CA4
SCHEMBL8086426 0.80 TPMT (0.51) TPMTCA12CA1CA2CA4
3,4,5-Trimethoxybenzoic Acid SCHEMBL9739818 0.80 TPMT (0.75) TPMTCA12CA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7875631-B2 e.g.1-(3,5-dichlorophenyl)-2-formyl-6-methoxy-1,2,3,4-tetrahydroisoquinoline; to prevent and/or treat cancer and other abnormal cell growth, and metabolic as well as blood vessel proliferate disorders, in which uncontrolled expression of insulin-like growth factor-1 receptor is observed ANALYTECON S.A. (CH) 2011-01-25 US disclosed
US-5824690-A TREATING ASTHMA, COUGH HOECHST MARION ROUSSEL INC. (US) 1998-10-20 US disclosed